Photo detail

Halozyme CEO Helen Torley poses in front of the company’s San Diego office. The biotech recently inked another deal with pharmaceutical giant Roche. File photo by Jamie Scott Lytle

Stories this photo appears in:

Halozyme Licenses Drug Delivery Technology to Roche

Halozyme Therapeutics is expanding the reach of its platform that delivers drugs under the skin, intended to do away with lengthy infusions.

Tease photo